ScreenerHero

TIL Instil Bio, Inc.

NAS · US · Healthcare · Biotechnology · instilbio.com
6.900USD+0.22%Mkt Cap: 46.80M $P/E: —

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with signif…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap46.80M USD
Enterprise Value64.44M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-71.37M USD
Revenue/Share—
Last Price6.900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.47
PEG—
EV/EBITDA-1.76
EV/Revenue—
P/S—
P/B0.43
EPS (TTM)-4.39
EPS (Forward)-14.64
52W Range
5.6708% of range21.98
52W High21.98 USD
52W Low5.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-62.68%
ROA-35.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.62M USD
CapEx (TTM)10.00M USD
FCF Margin—
FCF Yield174.83%
Net Debt17.74M USD
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity0.75
Current Ratio21.67
Quick Ratio21.09
Book Value/Sh15.83 USD
Cash/Share10.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateDec 8, 2023
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+1.4%
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.6.78M
Float3.66M
Insiders6.56%
Institutions62.50%
Short Interest
Short Ratio16.8d
Short % Float4.02%
Short % Out.2.39%
Shares Short161.87K
Short (prev mo.)176.32K
Technical
SMA 507.364 (-6.3%)
SMA 2008.012 (-13.9%)
Beta1.94
S&P 52W Chg16.45%
Avg Vol (30d)12.14K
Avg Vol (10d)12.43K
Technical Indicators
RSI (14)36.4
MACD-0.1278
MACD Signal-0.0954
MACD Hist.-0.0324
BB Upper7.713 USD
BB Middle7.237 USD
BB Lower6.761 USD
BB Width13.16%
ATR (14)0.2384 USD
Vol Ratio (20d)0.50x